MorphoSys AG
MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio—
52W High$19.5
52W Low$4.185
MorphoSys AG (MOR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MOR · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.28B | $0.18B | $0.33B | $0.07B |
| Cost of Revenue | $0.06B | $0.05B | $0.03B | $0.01B | $0.01B |
| Gross Profit | $0.18B | $0.23B | $0.15B | $0.32B | $0.06B |
| Gross Margin %(computed) | 75.51% | 82.53% | 82.07% | 97.20% | 83.16% |
| Operating Expenses | |||||
| R&D Expenses | $0.28B | $0.30B | $0.23B | $0.14B | $0.11B |
| G&A Expenses | $0.09B | $0.08B | $0.08B | $0.05B | $0.04B |
| Total Operating Expenses | $0.43B | $0.45B | $0.42B | $0.30B | $0.17B |
| Operating Income | ($0.25B) | $0.16B | ($0.28B) | $0.12B | ($0.11B) |
| Operating Margin %(computed) | -105.96% | 58.31% | -154.57% | 36.44% | -146.50% |
| Interest Income | $0.02B | $0.00B | $0.10B | $0.09B | $0.00B |
| Interest Expense | $0.11B | $0.12B | $0.18B | $0.10B | $0.00B |
| Income Before Tax | ($0.19B) | $0.02B | ($0.59B) | $0.02B | ($0.11B) |
| Income Tax Expense | ($0.00B) | $0.17B | ($0.08B) | ($0.08B) | ($0.00B) |
| Net Income | ($0.19B) | ($0.15B) | ($0.51B) | $0.10B | ($0.10B) |
| Net Margin %(computed) | -79.63% | -54.29% | -286.47% | 29.87% | -143.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.38 | $-1.10 | $-3.85 | $0.75 | $-0.81 |
| Wtd Avg Shares | 0.14B | 0.14B | 0.13B | 0.13B | 0.13B |
| EBITDA | ($0.10B) | $0.17B | ($0.33B) | $0.13B | ($0.10B) |
| EBITDA Margin %(computed) | -41.02% | 62.10% | -184.37% | 38.98% | -137.79% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more MorphoSys AG data
About MorphoSys AG (MOR) Income Statement
MorphoSys AG (MOR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MOR reported revenue of $0.24B, gross profit of $0.18B (gross margin 75.51%), and net income of ($0.19B) — a net profit margin of -79.63%.
Frequently asked questions
MOR · 4 questionsMorphoSys AG (MOR) reported revenue of $0.24B for 2023, down 14.4% year-over-year.
MOR revenueMOR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08